No Result
View All Result
SUBMIT YOUR ARTICLES
  • Login
Saturday, October 4, 2025
TheAdviserMagazine.com
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
No Result
View All Result
TheAdviserMagazine.com
No Result
View All Result
Home Market Research Business

Analysts see huge upside in Teva

by TheAdviserMagazine
2 months ago
in Business
Reading Time: 3 mins read
A A
Analysts see huge upside in Teva
Share on FacebookShare on TwitterShare on LInkedIn


Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) last week published its second quarter financial results in which it presented lower revenue but higher profit than predicted by the analysts – $4.2 billion and $0.66 per share respectively. Teva also raised sales guidance for branded drugs and annual profit guidance. On the day the report was published, Teva’s share price rose 1.8% on Wall Street but in the following days fell 8.6%. This morning Teva is down 4.74% on the Tel Aviv Stock Exchange (TASE).

Since the start of 2025, Teva has underperformed compared to other major companies in the sector. Since the start of the year the company’s share price has fallen 30.2% compared with an average fall of 4.8% in the S&P health care sector indices. The latest fall comes after a phenomenal year for Teva in 2024, in which it doubled its value. Today, after recent declines, the company’s stock has a market cap of $9 billion.

According to “The Wall Street Journal,” the average target price of 11 investment institutions covering Teva’s stock is $24.29, a 57.9% premium on the current share price, and almost all of them have positive recommendations for the stock.

Oppenheimer: “Excellent buying opportunity”

One of the investment banks whose price target for Teva’s stock is among the highest is Oppenheimer with a price target of $30, 95.1% higher than the price on the NYSE. Oppenheimer’s recommendation for Teva is “outperform.”

Oppenheimer writes, “In our opinion, the current market value of Teva’s stock does not reflect its future earnings potential, and constitutes an excellent buying opportunity for long-term investors.”

Oppenheimer adds, “Teva reported excellent results for the second quarter of the year and affirmed its strategic aims for 2027.” Teva’s aims for 2027 include a non-GAAP operating margin of 30%. In May Teva reported laying off 8% of its workforce – about 3,000 employees by 2027 – in order to save $700 million. The company’s CEO Richard Francis said after publication of the results last week that there is rapid progress in the plan, which is already generating annual savings for the company of $140 million in 2025.

Oppenheimer notes that achieving the 2027 aims needs significant growth in sales of branded drugs, operational efficiency and higher profit margins from branded drugs, which will allow creation of strong free cash flow. In their assessment, Teva will be able to achieve the aims earlier than expected. According to the Oppenheimer analysts, the drug Duvakitug, which is being developed together with Sanofi for gastrointestinal infections, is expected to begin phase 3 clinical trials in the fourth quarter, thus making Teva eligible for a payment of $500 million from Sanofi. In their assessment, the drug will be of equal importance to Copaxone in the future and may even overtake it in revenue in the far future.





RELATED ARTICLES




Teva again raises profit guidance


Israeli institutional investors bet on Teva


Teva launches startup challenge program


Teva gives aggressive guidance for innovative drugs






The sale of Teva’s active ingredients division will free up capital. Management said that a final decision will be made during the current quarter, and Oppenheimer estimates that its value will be $1.5-2 billion. “The US government places special emphasis on the sustainability of supply chains, and therefore this is likely to have a positive impact on the price that Teva is able to demand in the deal.”

Can rise by tens of percent?

Not only Oppenheimer believes in the Israeli pharmaceutical giant. A recent “Globes” survey of 14 institutional investors in the Israeli capital market found that many of them believed Teva’s stock is undervalued. For example, Migdal noted that it “currently trades at a 6.5-fold earnings multiple. Our assumption is that as confidence in revenue and profit levels in the coming years increases, the company will begin to trade at an earnings multiple that is more similar to ethical companies (branded drug manufacturers), which could result in a share price of $23-27.” This is while the stock is currently trading at a price that is over 50% lower.

Migdal believes that Teva is on the right track to get there, after over the past decade, “Succeeding in reducing debt 60%, significantly cutting expenses, improving production efficiency and creating a broader revenue mix, with a variety of new branded drugs. In addition, the company has built an impressive branded drug pipeline that is expected to provide it with a growth engine in the coming years.”

At the same time, Shmuel Ben-Arie, CIO at Pioneer Capital Management, also estimated last week in an interview with Globes that Teva is trading at a relatively low cash flow multiple, “and could easily rise 30%-40% in the coming year.”

Published by Globes, Israel business news – en.globes.co.il – on August 4, 2025.

© Copyright of Globes Publisher Itonut (1983) Ltd., 2025.




Source link

Tags: analystsHugeTevaUpside
ShareTweetShare
Previous Post

10 Cheap, Beautiful Places To Retire

Next Post

Sorting Out Covid Vaccine Confusion: New and Conflicting Federal Policies Raise Questions

Related Posts

edit post
Trump to federalize 300 members of the Illinois National Guard ahead of expected deployment to Democratic state

Trump to federalize 300 members of the Illinois National Guard ahead of expected deployment to Democratic state

by TheAdviserMagazine
October 4, 2025
0

The Trump administration plans to federalize 300 members of the Illinois National Guard, Democratic Gov. JB Pritzker said Saturday. Pritzker...

edit post
Spot crypto ETFs outperform trusts and strategy funds (BTC-USD:Cryptocurrency)

Spot crypto ETFs outperform trusts and strategy funds (BTC-USD:Cryptocurrency)

by TheAdviserMagazine
October 4, 2025
0

Chinnapong/iStock Editorial via Getty ImagesInvestors seeking bitcoin or ether exposure without directly holding coins now have three main choices: crypto...

edit post
If you’re not an AI startup, good luck raising money from VCs

If you’re not an AI startup, good luck raising money from VCs

by TheAdviserMagazine
October 4, 2025
0

Image Credits:Getty Images New PitchBook data illustrates how dramatically AI is dominating startup investment, with 2025 on-track to become the...

edit post
Apollo Global, Citi, Robinhood among week’s biggest financial movers

Apollo Global, Citi, Robinhood among week’s biggest financial movers

by TheAdviserMagazine
October 4, 2025
0

Oct. 04, 2025 1:33 PM ETC, WFC, GL, RJF, IBKR, CINF, IVZ, APO, COIN, HOODBy: Gaurav Batavia, SA News EditorDKosigThis...

edit post
Tens of thousands march in Barcelona and Rome to protest Israel’s campaign in Gaza

Tens of thousands march in Barcelona and Rome to protest Israel’s campaign in Gaza

by TheAdviserMagazine
October 4, 2025
0

Tens of thousands of people marched in Barcelona on Saturday and big crowds turned out in Rome for a second...

edit post
NATO ally warns of ‘hybrid war’ threat from Russia as drones plague European military bases and airports

NATO ally warns of ‘hybrid war’ threat from Russia as drones plague European military bases and airports

by TheAdviserMagazine
October 4, 2025
0

Denmark, a founding member of NATO, has added to growing alarms about the threat of “hybrid war” from Russia as...

Next Post
edit post
Sorting Out Covid Vaccine Confusion: New and Conflicting Federal Policies Raise Questions

Sorting Out Covid Vaccine Confusion: New and Conflicting Federal Policies Raise Questions

edit post
Prague-based Resistant AI secures strategic investment from Experian to combat APP fraud

Prague-based Resistant AI secures strategic investment from Experian to combat APP fraud

  • Trending
  • Comments
  • Latest
edit post
What Happens If a Spouse Dies Without a Will in North Carolina?

What Happens If a Spouse Dies Without a Will in North Carolina?

September 14, 2025
edit post
California May Reimplement Mask Mandates

California May Reimplement Mask Mandates

September 5, 2025
edit post
Does a Will Need to Be Notarized in North Carolina?

Does a Will Need to Be Notarized in North Carolina?

September 8, 2025
edit post
DACA recipients no longer eligible for Marketplace health insurance and subsidies

DACA recipients no longer eligible for Marketplace health insurance and subsidies

September 11, 2025
edit post
‘Quiet luxury’ is coming for the housing market, The Corcoran Group CEO says. It’s not just the Hamptons, Aspen, and Miami anymore

‘Quiet luxury’ is coming for the housing market, The Corcoran Group CEO says. It’s not just the Hamptons, Aspen, and Miami anymore

September 9, 2025
edit post
Tips to Apply for Mental Health SSDI Without Therapy

Tips to Apply for Mental Health SSDI Without Therapy

September 19, 2025
edit post
Walmart’s bold move in logistics

Walmart’s bold move in logistics

0
edit post
Taiwan Declines US Demand To Offshore Chip Production

Taiwan Declines US Demand To Offshore Chip Production

0
edit post
Robert Kiyosaki Wants to Vomit as Buffett Words Signal Crash Ahead, Doubles Down on Bitcoin

Robert Kiyosaki Wants to Vomit as Buffett Words Signal Crash Ahead, Doubles Down on Bitcoin

0
edit post
When the Choir Dies Out: How Religious Life Changes After Loss of Spouse

When the Choir Dies Out: How Religious Life Changes After Loss of Spouse

0
edit post
States Already Cutting Medicaid, Massive Federal Cuts Yet to Come

States Already Cutting Medicaid, Massive Federal Cuts Yet to Come

0
edit post
NSE cuts Nifty derivatives lot size to 65, revises contract sizes for other key indices from Dec 30

NSE cuts Nifty derivatives lot size to 65, revises contract sizes for other key indices from Dec 30

0
edit post
Robert Kiyosaki Wants to Vomit as Buffett Words Signal Crash Ahead, Doubles Down on Bitcoin

Robert Kiyosaki Wants to Vomit as Buffett Words Signal Crash Ahead, Doubles Down on Bitcoin

October 4, 2025
edit post
Stablecoin Yield Means Banks Must Now offer Customers Real Interest

Stablecoin Yield Means Banks Must Now offer Customers Real Interest

October 4, 2025
edit post
Trump to federalize 300 members of the Illinois National Guard ahead of expected deployment to Democratic state

Trump to federalize 300 members of the Illinois National Guard ahead of expected deployment to Democratic state

October 4, 2025
edit post
Our Favorite Zucchini Bread Recipe

Our Favorite Zucchini Bread Recipe

October 4, 2025
edit post
Spot crypto ETFs outperform trusts and strategy funds (BTC-USD:Cryptocurrency)

Spot crypto ETFs outperform trusts and strategy funds (BTC-USD:Cryptocurrency)

October 4, 2025
edit post
If you’re not an AI startup, good luck raising money from VCs

If you’re not an AI startup, good luck raising money from VCs

October 4, 2025
The Adviser Magazine

The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.

CATEGORIES

  • 401k Plans
  • Business
  • College
  • Cryptocurrency
  • Economy
  • Estate Plans
  • Financial Planning
  • Investing
  • IRS & Taxes
  • Legal
  • Market Analysis
  • Markets
  • Medicare
  • Money
  • Personal Finance
  • Social Security
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • Robert Kiyosaki Wants to Vomit as Buffett Words Signal Crash Ahead, Doubles Down on Bitcoin
  • Stablecoin Yield Means Banks Must Now offer Customers Real Interest
  • Trump to federalize 300 members of the Illinois National Guard ahead of expected deployment to Democratic state
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • Contact us
  • About Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.